Mangoceuticals (MGRX) Current Assets (2022 - 2026)

Mangoceuticals has disclosed Current Assets across 5 years of filings, most recently posting $212472.0 for Q1 2026.

• Current Assets for Q1 2026 came in at $212472.0, up 20.28% year-over-year; the trailing twelve-month figure through Mar 2026 was $212472.0 (up 20.28% YoY), and the FY2025 annual result was $1.5 million, up 1947.01% from the prior year.
• Current Assets came in at $212472.0 for Q1 2026 at Mangoceuticals, down from $1.5 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $3.8 million in Q1 2023 to a low of $75595.0 in Q4 2024.
• The 5-year median for Current Assets is $557892.0 (2024), against an average of $939909.3.
• Across the five-year window, Current Assets slumped 97.65% in 2024 and jumped 1947.01% in 2025, its largest moves.
• Mangoceuticals' Current Assets stood at $694605.0 in 2022, then rose by 20.27% to $835402.0 in 2023, then slumped by 90.95% to $75595.0 in 2024, then surged by 1947.01% to $1.5 million in 2025, then slumped by 86.27% to $212472.0 in 2026.
• The last three Current Assets figures came in at $212472.0 (Q1 2026), $1.5 million (Q4 2025), and $598223.0 (Q3 2025), per Business Quant data.